Ursula Elsässer-Beile - Search Results

Year	Number of Results
2003	2
2005	2
2006	1
2008	2
2009	5
2010	8
2011	2
2012	2
2013	2
2014	1
2015	1
2024	0

1

Bispecific antibodies and diabodies for cancer immunotherapy.

Elsässer-Beile U, Bühler P. Elsässer-Beile U, et al. Immunotherapy. 2012 May;4(5):459-60. doi: 10.2217/imt.12.18. Immunotherapy. 2012. PMID: 22642325 No abstract available.

2

Targeting the prostate-specific membrane antigen for prostate cancer therapy.

Bühler P, Wolf P, Elsässer-Beile U. Bühler P, et al. Among authors: elsasser beile u. Immunotherapy. 2009 May;1(3):471-81. doi: 10.2217/imt.09.17. Immunotherapy. 2009. PMID: 20635963 Review.

3

Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.

Wolf P, Elsässer-Beile U. Wolf P, et al. Among authors: elsasser beile u. Int J Med Microbiol. 2009 Mar;299(3):161-76. doi: 10.1016/j.ijmm.2008.08.003. Epub 2008 Oct 23. Int J Med Microbiol. 2009. PMID: 18948059 Review.

4

Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.

Liu J, Kopečková P, Pan H, Sima M, Bühler P, Wolf P, Elsässer-Beile U, Kopeček J. Liu J, et al. Among authors: elsasser beile u. Macromol Biosci. 2012 Mar;12(3):412-22. doi: 10.1002/mabi.201100340. Macromol Biosci. 2012. PMID: 22493797 Free PMC article.

5

In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancer.

Behe M, Alt K, Deininger F, Bühler P, Wetterauer U, Weber WA, Elsässer-Beile U, Wolf P. Behe M, et al. Among authors: elsasser beile u. In Vivo. 2011 Jan-Feb;25(1):55-9. In Vivo. 2011. PMID: 21282735

6

Activation of RhoA,B,C by Yersinia Cytotoxic Necrotizing Factor (CNFy) induces apoptosis in LNCaP prostate cancer cells.

Augspach A, List JH, Wolf P, Bielek H, Schwan C, Elsässer-Beile U, Aktories K, Schmidt G. Augspach A, et al. Among authors: elsasser beile u. Toxins (Basel). 2013 Nov 21;5(11):2241-57. doi: 10.3390/toxins5112241. Toxins (Basel). 2013. PMID: 24284827 Free PMC article.

7

Non-invasive in vivo imaging of tumor-associated CD133/prominin.

Tsurumi C, Esser N, Firat E, Gaedicke S, Follo M, Behe M, Elsässer-Beile U, Grosu AL, Graeser R, Niedermann G. Tsurumi C, et al. Among authors: elsasser beile u. PLoS One. 2010 Dec 20;5(12):e15605. doi: 10.1371/journal.pone.0015605. PLoS One. 2010. PMID: 21187924 Free PMC article.

8

Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.

Baum V, Bühler P, Gierschner D, Herchenbach D, Fiala GJ, Schamel WW, Wolf P, Elsässer-Beile U. Baum V, et al. Among authors: elsasser beile u. Immunotherapy. 2013 Jan;5(1):27-38. doi: 10.2217/imt.12.136. Immunotherapy. 2013. PMID: 23256796

9

Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.

Bühler P, Wetterauer D, Gierschner D, Wetterauer U, Beile UE, Wolf P. Bühler P, et al. Among authors: beile ue. Anticancer Res. 2010 Sep;30(9):3373-9. Anticancer Res. 2010. PMID: 20944111

10

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells.

Prasad S, Gaedicke S, Machein M, Mittler G, Braun F, Hettich M, Firat E, Klingner K, Schüler J, Wider D, Wäsch RM, Herold-Mende C, Elsässer-Beile U, Niedermann G. Prasad S, et al. Among authors: elsasser beile u. Cancer Res. 2015 Jun 1;75(11):2166-76. doi: 10.1158/0008-5472.CAN-14-2415. Epub 2015 Apr 3. Cancer Res. 2015. PMID: 25840983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year